Dr. Michael S. Conjalka, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 600 Roe Avenue, Falck Cancer Center, Elmira, NY 14905 Phone: 607-737-8165 Fax: 607-737-8175 |
Dr. Serge Dauphin, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 600 Roe Ave, Elmira, NY 14905 Phone: 607-737-8165 Fax: 607-737-6175 |
News Archive
Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers further scientific support for using the Noveon lasers as an effective therapeutic treatment.
Onyx Pharmaceuticals, Inc. today announced that it has filed a complaint in the United States District Court for the Northern District of California asserting its rights to a Phase 2 anti-cancer compound discovered during joint research between Onyx and Bayer.
The Department of Health and Human Services reported Friday that 7.2 million people gained insurance through these programs since the health law's eligibility changes began last October. In addition, Arkansas and New Hampshire offer snapshots of their states' enrollment pictures, while Kansas and Missouri hospitals brace for the price of state decisions not to expand the low-income health insurance program.
In genetic mapping of a large family with several members affected by a type of heart failure called dilated cardiomyopathy (DCM), the Mayo Clinic team found a defect in a gene on chromosome 3 called SCN5A.
› Verified 4 days ago